PB1884: ENGAGING INNATE IMMUNITY: A PHASE 1 DOSE ESCALATION STUDY TO ASSESS SAFETY AND TOLERABILITY OF AFM28 MONOTHERAPY IN PATIENTS WITH RELAPSED/REFRACTORY CD123-POSITIVE ACUTE MYELOID LEUKEMIA (AML)

Detalles Bibliográficos
Autores principales: Arnan, Montserrat, Montesinos, Pau, de Botton, Stéphane, Recher, Christian, Wunderle, Lydia, Emig, Michael, Harstrick, Andreas, Pietzko, Kerstin, Pinto, Sheena, Ravenstijn, Paulien, Daver, Naval
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Publication Only
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430174/
http://dx.doi.org/10.1097/01.HS9.0000974360.24047.92

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430174/
http://dx.doi.org/10.1097/01.HS9.0000974360.24047.92

Ejemplares similares